Nureca Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Nureca Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹400
Per ShareLot Size
35 Shares
Minimum Investment
₹14,000
Issue Size
₹100 Cr
Face Value
₹10
Per ShareIPO Type
Book Building
Retail Quota
10%
QIB Quota
75%
NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Nureca Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
93.33%
Promoter Holding (Post-Issue)
69.82%
Issue Type
Book Building
ISIN
INE0DSF01015
About the Company
Nureca Limited is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. The Company enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It believes in innovation and catering new products to the ever-growing needs of the home health care sector. The Company is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, the company also sells its products through its own website drtrust.in.
Industry Overview
The Home Health Market in India and neighbouring countries is pegged at Rs. 20,757.0 Cr in 2019 and is expected to grow to Rs. 38,920.7 Cr by 2025 at a CAGR 11.0%. The growth is driven by rising awareness of Health and wellness, increasing spending power, growing burden of chronic diseases, and the need for Healthcare stakeholders to reduce healthcare costs.
Company History
Nureca Limited was incorporated as 'Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019, for change of state issued by the Registrar of Companies, Maharashtra at Mumbai ("RoC") with effect from February 8, 2019. Pursuant to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to its present name ureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.
Products & Services
- Home Healthcare and Wellness Products
Growth Strategy
- Diversifying and strengthening its market by enabling it to cater to a wide range of geographies and customer segments
- Strengthening its business through product innovation and new product launches
- Strengthening up its business through effective branding, promotional and digital activities
- Retain and attract the best talent and develop a performance focused culture
Customer Base
Wholesalers and Retailers
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial Public Offering of 25,00,175 equity shares of face value Rs. 10 each ("equity shares") of the company for cash at a price of Rs. 400 per equity share (including a share premium of Rs. 390 per equity share) ("Issue Price"), Aggregating Rs. 100.00 Crores ("Issue"). The issue includes a reservation of 26,315 equity shares aggregating to Rs. 1 crores for purchase by Eligible Employees ("The Employee Reservation Portion"). The issue less the employee reservation portion is hereinafter referred to as the "Net Issue". The Issue and the net issue constitutes 25.00% and 24.74%, Respectively of the post-issue paid-up equity share capital of the company. Issue Price : Rs. 400 per Equity Share of face value of Rs. 10 each.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Diversified product portfolio addressing the needs of varied customers across home healthcare industry
- Well-recognized brand with a targeted marketing strategy
- Wide sales and distribution network
- Experienced Promoters with strong management team having domain knowledge
- Proven track record of robust financial performance
- The Company depends on third parties to manufacture its products. If these organizations are unable or unwilling to manufacture its products, or if these organizations fail to comply with FDA or other applicable regulations or otherwise fail to meet its requirements, its business will be harmed.
- The Company depends heavily on its channel partners such as third party e-commerce players, distributors and retailers and failure to manage the distribution network efficiently will adversely affect its performance.
- The Promoter, members of the Promoter Group and some of its Directors have been subject to a earch and seizure' operation by the income-tax department. Any adverse determination by the tax authorities in this matter could increase the tax liability and which may result in taxation and other proceedings against such individuals.
- It is dependent on the maintenance of existing product lines and service relationships, market acceptance of new product and service introductions and innovations for revenue and earnings growth.
- The Company has experienced negative cash flows, and may continue to do so in the future, which could have a material adverse effect on its business, prospects, financial condition, cash flows and results of operations.